Potentia's Proteus biotechnology platform takes advantage of one of the most powerful homeostatic systems of the human body: the removal and recycling of dead cells by macrophages. Proteus directs this system to remove unwanted living cells of any type and has the potential to modulate inflammation locally.
Potentia will apply this technology to address key aspects of age-related macular degeneration (AMD).

